ArticleMolecular neurobiology2025
DTX1 Modulates Microglial M1 Polarization and Exacerbates Neuroinflammation in Traumatic Brain Injury Model Rats through NF-κB/IRF5.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Nitric oxide and traumatic brain injury.Medical gas research · 2027Review
- The role of IRF5 as an immune regulator.Biochemical Society transactions · 2026Review
- The expanding landscape of Deltex: signaling crosstalk and clinical implications.Cellular and molecular life sciences : CMLS · 2026Review
- Intracranial LPS injection induces cerebral palsy-like motor and behavioral deficits in immunodeficient mice.Scientific reports · 2026Article
- Gastrodin alleviates neuronal damage in epileptic cell models by targeting P2RY12 to inhibit microglial hyperactivation.PloS one · 2026Article
- Targeting the blood-brain barrier with phytochemicals to attenuate vascular cognitive impairment: mechanisms and therapeutic potential across etiologies.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Microglial polarization is crucial in the pathogenesis of traumatic brain injury (TBI), yet the underlying regulatory mechanisms remain incompletely understood. In this study, we investigated the role of Deltex E3 ubiquitin ligase 1 (DTX1) in modulating microglial polarization and neuroinflammation following TBI. We established a rat TBI model and conducted both gain- and loss-of-function experiments by delivering adenoviral vectors encoding DTX1 or siRNA-DTX1-liposome complexes in vivo (into the injured rat brain) and in vitro (into cultured microglial cells). We found that that DTX1 expression was significantly upregulated in lipopolysaccharide (LPS)-stimulated microglia and in post-TBI rat brains. Overexpression of DTX1 promoted proinflammatory cytokine production and shifted microglia toward the M1 phenotype, as indicated by elevated inducible nitric oxide synthase (iNOS) and reduced arginase-1 (Arg1). Conversely, silencing DTX1 decreased iNOS and increased Arg1 expression, indicative of a shift toward the anti-inflammatory M2 phenotype. In vivo, DTX1 overexpression exacerbated neuroinflammation and cognitive deficits, whereas DTX1 knockdown mitigated these outcomes. In summary, these results identify DTX1 as a critical regulator of microglial polarization and neuroinflammation and suggest its potential as a therapeutic target for TBI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.